Search Database

Select Protein (1 found)

UniProt ID Gene Symbol Protein Name Organism Length Action
Q8NHU3 SGMS2; SMS2 Phosphatidylcholine:ceramide cholinephosphotransferase 2 (EC 2.7.8.27) … Homo sapiens (Human) 365 aa

Protein Details: Q8NHU3 (SGMS2)

Protein Information
Accession Q8NHU3
Protein Names Phosphatidylcholine:ceramide cholinephosphotransferase 2 (EC 2.7.8.27) (Sphingomyelin synthase 2) (SMS2)
Gene Symbol SGMS2; SMS2
Organism Homo sapiens (Human)
Length 365 aa
Isoforms No isoforms
Related PMIDs 31251020
Database Sources dbPTM SwissPalm
These studies detected palmitoylation of this protein in the samples.
Tissue/Cell Line Expression
Tissue Specificity Index (TSI): 1.000
Bubble Size: Positive Samples Count Color Intensity: Positive Ratio
25
LNCaP cells
Specificity: 1.000
25/46 (54.3%)
0
Jurkat T cells
Specificity: 0.000
0/25 (0.0%)
0
U937 cells
Specificity: 0.000
0/1 (0.0%)
0
DU145 cells
Specificity: 0.000
0/2 (0.0%)
0
HeLa cells
Specificity: 0.000
0/1 (0.0%)
0
PC3 cells
Specificity: 0.000
0/4 (0.0%)
0
T cells
Specificity: 0.000
0/4 (0.0%)
0
HAP1 cells
Specificity: 0.000
0/10 (0.0%)
0
293T cells
Specificity: 0.000
0/10 (0.0%)
0
CEMx174 cells
Specificity: 0.000
0/3 (0.0%)
0
Endothelial cells
Specificity: 0.000
0/2 (0.0%)
0
Prefrontal cortex
Specificity: 0.000
0/1 (0.0%)
0
Cerebral cortex
Specificity: 0.000
0/4 (0.0%)
0
Liver membrane
Specificity: 0.000
0/1 (0.0%)
Palmitoylation Distribution by Study and Tissue/Cell Line
Chart Explanation: Each bar represents a study (PMID). The colored bottom segment shows palmitoylated samples, while the gray top segment shows non-palmitoylated samples. Bars are grouped by tissue/cell line for easy comparison.
Protein Sequence
Single Types:
Experimental Database High Prediction Medium Prediction Low Prediction
Combined Types:
All Three Exp + DB Exp + High Pred Exp + Med Pred Exp + Low Pred DB + High Pred DB + Med Pred DB + Low Pred Cysteine
1-501MDIIETAKLE11EHLENQPSDP21TNTYARPAEP31VEEENKNGNG41KPKSLSSGLR
51-10051KGTKKYPDYI61QIAMPTESRN71KFPLEWWKTG81IAFIYAVFNL91VLTTVMITVV
101-150101HERVPPKELS111PPLPDKFFDY121IDRVKWAFSV131SEINGIILVG141LWITQWLFLR
151-200151YKSIVGRRFC161FIIGTLYLYR171CITMYVTTLP181VPGMHFQCAP191KLNGDSQAKV
201-250201QRILRLISGG211GLSITGSHIL221CGDFLFSGHT231VTLTLTYLFI241KEYSPRHFWW
251-300251YHLICWLLSA261AGIICILVAH271EHYTIDVIIA281YYITTRLFWW291YHSMANEKNL
301-350301KVSSQTNFLS311RAWWFPIFYF321FEKNVQGSIP331CCFSWPLSWP341PGCFKSSCKK
351-365351YSRVQKIGED361NEKST
Palmitoylation Sites Details
Position Sources Domains Experimental PMIDs
160 Prediction (High) - -
331 DBPTM SWISSPALM Prediction (Medium) - -
332 DBPTM SWISSPALM Prediction (Medium) - -
343 DBPTM SWISSPALM Prediction (Medium) - -
348 DBPTM SWISSPALM Prediction (Medium) - -
Conservation Scores
PhyloP
PhastCons
TCGA Cysteine Mutation Information

Note: Mutations indicate amino acid changes that may create potential palmitoylation sites.

Position Amino Acid Change Frequency Type Function Cancer Type
171 C → Y 0.002506 SNP Missense Mutation COAD
246 R → C 0.001887 SNP Missense Mutation UCEC
265 C → Y 0.002294 SNP Missense Mutation OV
332 C → _F333insLQ 0.001014 INS In Frame Ins BRCA
332 C → _F333insLQ 0.001887 INS In Frame Ins UCEC
348 C → R 0.002288 SNP Missense Mutation STAD
331* C → ? 0.007299 SNP Nonsense Mutation READ
255* C → ? 0.001887 SNP Nonsense Mutation UCEC